Therapeutic Advances in Medical Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.1 | Q2 | 67.0% | 1.416 | Q1 | 91.1% |
| 2024 | 4.2 | Q2 | 73.0% | 1.549 | Q1 | 92.7% |
| 2023 | 4.3 | Q2 | 69.8% | 1.529 | Q1 | 92.9% |
| 2022 | 4.9 | Q2 | 70.1% | 1.514 | Q1 | 93.2% |
| 2021 | 5.5 | Q2 | 71.4% | 1.488 | Q1 | 93.0% |
| 2020 | — | — | 2.272 | Q1 | 96.4% | |
| 2019 | — | — | 2.304 | Q1 | 96.6% | |
| 2018 | — | — | 2.200 | Q1 | 95.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1758-8359
ISSN
1758-8340
country
UScoverage
2009-2026